首页 正文

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer

{{output}}
Prostate cancer (PC) is one of the most common cancers and is a leading cause of death. Its initial growth is dependent on androgens; most patients show an initial response to hormonal therapy but will experience disease progression when PC becomes resistant t... ...